Longitudinal changes in uric acid concentration and their relationship with chronic kidney disease progression in children and adolescents

被引:4
作者
Schwartz, George J. [1 ]
Roem, Jennifer L. [2 ]
Hooper, Stephen R. [3 ]
Furth, Susan L. [4 ]
Weaver, Donald J., Jr. [5 ]
Warady, Bradley A. [6 ]
Schneider, Michael F. [2 ]
机构
[1] Univ Rochester, Pediat, Med Ctr, 601 Elmwood Ave Box 777, Rochester, NY 14642 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol, Baltimore, MD USA
[3] Univ N Carolina, Allied Hlth Sci, Chapel Hill, NC 27515 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Pediat, Philadelphia, PA 19104 USA
[5] Atrium Hlth Levine Hosp, Pediat, Charlotte, NC USA
[6] Univ Missouri, Childrens Mercy Hosp, Pediat, Sch Med, Kansas City, MO USA
关键词
Uric acid; eGFR; Chronic Kidney Disease; Kidney progression; Pediatrics; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; RISK-FACTOR; HYPERURICEMIA; ALLOPURINOL; FEBUXOSTAT; CHILDHOOD; EXCRETION;
D O I
10.1007/s00467-022-05620-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Elevated serum uric acid concentration is a risk factor for CKD progression. Its change over time and association with CKD etiology and concomitant changes in estimated glomerular filtration rate (eGFR) in children and adolescents are unknown. Methods Longitudinal study of 153 children/adolescents with glomerular (G) and 540 with non-glomerular (NG) etiology from the CKD in Children (CKiD) study. Baseline serum uric acid, change in uric acid and eGFR over time, CKD etiology, and comorbidities were monitored. Adjusted linear mixed-effects regression models quantified the relationship between within-person changes in uric acid and concurrent within-person changes in eGFR. Results Participants with stable uric acid over follow-up had CKD progression which became worse for increased baseline uric acid (average annual percentage changes in eGFR were - 1.4%, - 7.7%, and - 14.7% in those with G CKD with baseline uric acid < 5.5 mg/dL, 5.5 - 7.5 mg/dL, and > 7.5 mg/dL, respectively; these changes were - 1.4%, - 4.1%, and - 8.6% in NG CKD). Each 1 mg/dL increase in uric acid over follow-up was independently associated with significant concomitant eGFR decreases of - 5.7% (95%CI - 8.4 to - 3.0%) (G) and - 5.1% (95%CI - 6.3 to - 4.0%) (NG) for those with baseline uric acid < 5.5 mg/dL and - 4.3% (95%CI - 6.8 to - 1.6%) (G) and - 3.3% (95%CI - 4.1 to - 2.6%) (NG) with baseline uric acid between 5.5 and 7.5 mg/dL. Conclusions Higher uric acid levels and increases in uric acid over time are risk factors for more severe progression of CKD in children and adolescents.
引用
收藏
页码:489 / 497
页数:9
相关论文
共 46 条
  • [1] Effects of Allopurinol on the Progression of Chronic Kidney Disease
    Badve, Sunil V.
    Pascoe, Elaine M.
    Biostat, M.
    Tiku, Anushree
    Boudville, Neil
    Brown, Fiona G.
    Cass, Alan
    Clarke, Philip
    Dalbeth, Nicola
    Day, Richard O.
    de Zoysa, Janak R.
    Douglas, Bettina
    Faull, Randall
    Harris, David C.
    Hawley, Carmel M.
    Jones, Graham R. D.
    Kanellis, John
    Palmer, Suetonia C.
    Perkovic, Vlado
    Rangan, Gopala K.
    Reidlinger, Donna
    Robison, Laura
    Walker, Robert J.
    Walters, Giles
    Johnson, David W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26) : 2504 - 2513
  • [2] BALDREE LA, 1990, PEDIATR CLIN N AM, V37, P391
  • [3] Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study
    Ben-Dov, Iddo Z.
    Kark, Jeremy D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (08) : 2558 - 2566
  • [4] Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome
    Caletti, MG
    Lejarraga, H
    Kelmansky, D
    Missoni, M
    [J]. PEDIATRIC NEPHROLOGY, 2004, 19 (10) : 1148 - 1152
  • [5] A Comprehensive Analysis of Ontogeny of Renal Drug Transporters: mRNA Analyses, Quantitative Proteomics, and Localization
    Cheung, Kit Wun Kathy
    van Groen, Bianca D.
    Spaans, Edwin
    van Borselen, Marjolein D.
    de Bruijn, Adrianus C. J. M.
    Simons-Oosterhuis, Ytje
    Tibboel, Dick
    Samsom, Janneke N.
    Verdijk, Robert M.
    Smeets, Bart
    Zhang, Lei
    Huang, Shiew-Mei
    Giacomini, Kathleen M.
    de Wildt, Saskia N.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (05) : 1083 - 1092
  • [6] Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study
    Chou, Hsu-Wen
    Chiu, Hsien-Tsai
    Tsai, Ching-Wei
    Ting, I-Wen
    Yeh, Hung-Chieh
    Huang, Han-Chun
    Kuo, Chin-Chi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (09) : 1620 - 1627
  • [7] Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
    Chung T.-T.
    Yu K.-H.
    Kuo C.-F.
    Luo S.-F.
    Chiou M.-J.
    Lan W.-C.
    Chen J.-S.
    Tseng W.-Y.
    Hsieh A.-H.
    Wang L.-C.
    [J]. Arthritis Research & Therapy, 21 (1)
  • [8] Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
    Doria, A.
    Galecki, A. T.
    Spino, C.
    Pop-Busui, R.
    Cherney, D. Z.
    Lingvay, I.
    Parsa, A.
    Rossing, P.
    Sigal, R. J.
    Afkarian, M.
    Aronson, R.
    Caramori, M. L.
    Crandall, J. P.
    de Boer, I. H.
    Elliott, T. G.
    Goldfine, A. B.
    Haw, J. S.
    Hirsch, I. B.
    Karger, A. B.
    Maahs, D. M.
    McGill, J. B.
    Molitch, M. E.
    Perkins, B. A.
    Polsky, S.
    Pragnell, M.
    Robiner, W. N.
    Rosas, S. E.
    Senior, P.
    Tuttle, K. R.
    Umpierrez, G. E.
    Wallia, A.
    Weinstock, R. S.
    Wu, C.
    Mauer, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26) : 2493 - 2503
  • [9] Metabolic Abnormalities, Cardiovascular Disease Risk Factors, and GFR Decline in Children with Chronic Kidney Disease
    Furth, Susan L.
    Abraham, Alison G.
    Jerry-Fluker, Judith
    Schwartz, George J.
    Benfield, Mark
    Kaskel, Frederick
    Wong, Craig
    Mak, Robert H.
    Moxey-Mims, Marva
    Warady, Bradley A.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (09): : 2132 - 2140
  • [10] Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass
    Galan, Isabel
    Goicoechea, Marian
    Quiroga, Borja
    Macias, Nicolas
    Santos, Alba
    Garcia de Vinuesa, Maria Soledad
    Verdalles, Ursula
    Cedeno, Santiago
    Verde, Eduardo
    Perez de Jose, Ana
    Garcia, Ana
    Luno, Jose
    [J]. NEFROLOGIA, 2018, 38 (01): : 73 - 78